Compared to DLD1 and SW480, CRC cells with low RNF6 expression were less sensitive to the growth inhibitory effects of pladienolide B (Supplementary Table 6), consistent with a role of SF3B2 in mediating the oncogenic effect of RNF6. This evidence concerns the gene RNF6 and colorectal carcinoma.